Keyphrases
South Africa
100%
High-risk Human Papillomavirus (HR-HPV)
74%
Pretoria
37%
Tertiary Hospital
29%
Cervical Cancer
28%
Gynecology Clinic
28%
Healthcare Workers
28%
HPV16
26%
Papillomavirus Infections
24%
HIV-positive
24%
Hepatitis B Virus Infection
22%
HPV Types
21%
High Prevalence
21%
South African
18%
Penile Lesions
18%
South African Men
18%
Self-collected
18%
Human Papillomavirus Prevalence
18%
Occult Hepatitis B Virus Infection
18%
Oropharyngeal
18%
Quantitative PCR
18%
Revaccination
16%
Human Papillomavirus Types
15%
Vaccine Introduction
15%
Tamponade
15%
Hepatitis B Vaccine
14%
Cervical Cancer Screening
14%
Hepatitis B Virus
14%
Messenger RNA (mRNA)
14%
HPV Infection
13%
HIV Status
13%
Vaginal Sample
12%
Academic Hospital
12%
Deoxyribonucleic Acid
12%
Laser Capture Microdissection
12%
Gauteng Province
11%
Ilex
11%
Cervical Samples
11%
Cervical Cancer Prevention
11%
Resource-limited Settings
11%
Gene Variants
11%
Human Papillomavirus Testing
10%
Self-sampling
10%
Gargle
10%
Oral Sex
10%
Rinsing
10%
Human Cervical Spine
10%
HPV Vaccine
10%
Epidemiology
10%
Genetic Parameters
9%
Medicine and Dentistry
Wart Virus
95%
Prevalence
40%
Cervical Cancer
31%
Gynecology
28%
Human Papillomavirus Type 16
27%
Papillomavirus Infection
24%
Human Immunodeficiency Virus
23%
RNA
22%
Infection
19%
Real-Time Polymerase Chain Reaction
18%
Holly
15%
Cervical Cancer Screening
15%
DNA
15%
Human Papillomavirus Type 11
11%
Genotype
11%
Cervical Cancer Prevention
10%
Human Papillomavirus Type 18
10%
Squamous Cell Carcinoma
10%
Liquid-Based Cytology
9%
Esophageal Squamous Cell Carcinoma
9%
Esophageal Cancer
9%
Men Who Have Sex with Men
9%
Human Immunodeficiency Virus Prevalence
9%
Cancer
9%
Breast Cancer
9%
Breast Carcinoma
9%
Uterine Cervix Cytology
9%
Cytotechnology
9%
HIV Drug Resistance
9%
Malignant Neoplasm
8%
Mixed Infection
7%
Oral Sex
7%
Mouth
7%
Low and Middle Income Countries
7%
Precancerous Condition
6%
Polymerase Chain Reaction
6%
Persistent Infection
6%
Cervix
6%
Disease
5%
Immunology and Microbiology
Wart Virus
56%
Prevalence
44%
Hepatitis B Virus
35%
Hepatitis B
29%
Human Immunodeficiency Virus
24%
Vaccine Efficacy
20%
Squamous Cell
18%
Human Papillomavirus Type 16
13%
Vaccination Policy
13%
Hepatitis B Vaccination
13%
Real-Time Polymerase Chain Reaction
12%
Surface Property
12%
Laser Microdissection
11%
Genotype
10%
Polymerase Chain Reaction
5%
Monospecific Antibody
5%